NCT04568707View on ClinicalTrials.gov

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

NACompletedINTERVENTIONAL

Enrollment

238

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions

Covid19Neurologic ManifestationsPsychiatric Manifestations

Interventions

OTHER

blood sample

blood sample for serum (serology, biomarkers) and DNA

Trial Locations (1)

75013

Hôpital Pitié Salpétrière, Paris

All Listed Sponsors

collaborator

Paris Brain Institute (ICM)

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04568707 - Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES) | Biotech Hunter | Biotech Hunter